Gamma camera imaging of platinum in tumours and tissues of patients after administration of 191Pt-cisplatin

Acta Oncologica

Volumn 38, Issue 2, 1999, Pages 221-228

  Areberg, Johan ^a   Björkman, Sven ^a   Einarsson, Lars ^b   Frankenberg, Britt ^a   Lundqvist, Hans ^c   Mattsson, Sören ^a   Norrgren, Kristina ^a   Scheike, Ole ^a   Wallin, Ronnie ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; CISPLATIN; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; FOLINATE CALCIUM; METHOTREXATE; PLATINUM; VINBLASTINE;

ADULT; AGED; ARTICLE; BODY IMAGE; BRAIN TUMOR; CLINICAL ARTICLE; DRUG ACCUMULATION; FEMALE; GALLBLADDER; HUMAN; IMAGE DISPLAY; KIDNEY; LIVER; MALE; PHOTON; PRIORITY JOURNAL; SCINTILLATION CAMERA; TUMOR; TUMOR LOCALIZATION;

ADULT; AGED; ANTINEOPLASTIC AGENTS; CISPLATIN; FEMALE; GAMMA CAMERAS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PLATINUM; RADIATION-SENSITIZING AGENTS; RADIOISOTOPES; RADIOPHARMACEUTICALS;

EID: 0032948940     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/028418699431654     Document Type: Article

References (26)

1. 1. Muggia FM. Testicular cancer and the legacy of chemotherapy. Cancer Chemother Pharmacol 1985; 15: 1-5.
2. 2. Johnson NP, Hoeschele JD, Rahn RO. Kinetic analysis of the in vitro binding of radioactive cis-and trans-dichlorodiammineplatinum(II) to DNA. Chem Biol Interact 1980; 30: 151-69.
3. 3. Zamble DB, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends in Biochem Sci 1995; 20: 435-9.
4. 4. Takahashi K, Seki T, Nishikawa K, et al. Antitumor activity and toxicity of serum protein-bound platinum formed from cisplatin. Jpn J Cancer Res (Gann) 1985; 76: 68-74.
5. 5. Cavalli F, Tschopp L, Sonntag RW, Zimmermann A. A case of liver toxicity following cis-dichlorodiammineplatinum(II) treatment. Cancer Treatments Reports 1978; 62: 2125-6.
6. 6. Chu G, Mantin R, Shen YM, Baskett G, Sussman H. Massive cisplatin overdose by accidental substitution for carboplatin. Cancer 1993; 72: 3707-14.
7. 7. Jonson R, Börjesson J, Mattsson S, Unsgaard B, Wallgren A. Uptake and retention of platinum in patients undergoing cisplatin therapy. Acta Oncol 1991; 30: 315-9.
8. 8. Lange RC. Spencer RP, Harder HC. The antitumor agent cis-Pt(NH3)C12: Distribution studies and dose calculations for 193mPt and 195mPt. J Nucl Med 1972; 14: 191-5.
9. 9. Smith HS, Taylor DM. Distribution and retention of the antitumor agent 195mPt-cis-dichlorodiammine platinum (II) in man. J Nucl Med 1974; 15: 349-51.
10. 10. Owens SE, Thatcher H, Sharma H, et al. In vivo distribution studies of radioactively labelled platinum complexes; cis-dichlorodiammine platinum (II), cis-trans-dichlorodihydroxy-bis-(isopropylamine) platinum (IV), dis-dichloro-bis-cyclopropylamine platinum (III), and cis-diammine 1,1-cyclobutanedi-carboxylate platinum (II) in patients with malignant disease, using a gamma camera. Cancer Chemother Pharmacol 1985; 14: 253-7.
11. 11. Shani J, Bertram J, Russell C, et al. Noninvasive monitoring of drug biodistribution and metabolism: studies with intraarterial Pt-195m-cisplatin in humans. Cancer Res 1989; 49: 1877-81.
12. 12. Browne E, Firestone RB, Shirley VS. Table of radioactive isotopes, 8th edition. New York: John Wiley and Sons, 1986.
13. 13. Hoeschele JD, Butler TA, Roberts JA, Guyer CE. Analysis and refinement of the microscale synthesis of the 195mPt-labeled antitumor drug, cis-dichlorodiammineplatinum(II), cis-DDP. Radiochimica Acta 1982; 31: 27-36.
14. 14. Nuclear Medicine Procedure 5, Oak Ridge 19 July 1990, Health Physics Division, Oak Ridge National Laboratory, Oak Ridge, Tennessee 37830, USA.
15. 15. Riley CM, Sternson LA, Repta AJ. High performance liquid chromatography of cis-dichlorodiammineplatinum(II) using chemically-bonded and solvent-generated ion exchangers. J Chromatography 1981; 217: 405-20.
16. 16. Snyder WS, Ford MR, Warner GG. NM MIRD Pamphlet No. 5, revised - estimates of specific absorbed fractions for photon sources uniformly distributed in various organs of a heterogeneous phantom. New York: MIRD Pamphlets, Society of Nuclear Medicine, 1978.
17. 17. Williams LR, Leggett RW. Reference values for resting blood flow to organs of man. Clin Phys Physiol Meas 1989; 10: 187-217.
18. 18. Baer J, Harrison R, McAuliffe CA, Zaki A, Sharma HL, Smith AG. Microscale syntheses of anti-tumour platinum compounds labelled with 191Pt. Intg J Appl Radiat Isot 1985; 36: 181-4.
19. 19. Iosilevsky G, Israel O, Frenkel A, et al. A practical SPECT technique for quantification of drug delivery to human tumors and organ absorbed radiation dose. Semin Nucl Med 1989; XIX: 33-46.
20. 20. Hecquet B, Vennin P, Fournier C, et al. Platinum concentration in human tumors of head and neck, uterine cervix, and breast following treatment with cisplatin. Cancer Chemother Pharmacol 1985; 15: 310-2.
21. 21. Stewart DJ, Mikhael NZ, Nanji RC. et al. Renal and hepatic concentrations of platinum: relationship to cisplatin time, dose and nephrotoxicity. J Clin Oncol 1985; 3: 1251-6.
22. 22. Uozumi J, Ueda T. Yasumasu T, et al. Platinum accumulation in the kidney and liver following chemotherapy with cisplatin in humans. Int Urol Nephrol 1993; 25: 215-20.
23. 23. Tothill P, Klys HS, Matheson LM, McKay K, Smyth JF. The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. Eur J Cancer 1992; 28: 1358-61.
24. 24. Sharma H, Thatcher N, Baer J, et al. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum(II) (CBDCA) in cancer patients. Cancer Chemother Pharmacol 1985; 11: 5-7.
25. 25. Thatcher N, Sharma H, Harrisson R, et al. Blood clearance of three radioactively labelled platinum complexes: cis-dichlorodiammine platinum II, cis, trans-dichlorodihydroxy-bis-(isopropylamine) platinum IV, and cis-dichloro-bis-cycloporpylamine platinum II, in patients with malignant disease. Cancer Chemother Pharmacol 1982; 9: 13-6.
26. 26. Vermorken JB, van der Vijgh WJF, Klein I, et al. Pharmacokinetics of free and total platinum species after rapid and prolonged infusion of cisplatin. Clin Pharmacol Ther 1986; 39: 136-44.